Trial endpoints for systemic therapy in patients with hepatocellular carcinoma
- PMID: 30943424
- DOI: 10.1016/j.jhep.2019.03.001
Trial endpoints for systemic therapy in patients with hepatocellular carcinoma
Comment on
-
Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival.J Hepatol. 2019 Jun;70(6):1262-1277. doi: 10.1016/j.jhep.2019.01.028. Epub 2019 Mar 31. J Hepatol. 2019. PMID: 30943423 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical